Autophagy is triggered as a pro-survival strategy in human cancer cells treated with mammalian target of rapamycin (mTOR) inhibitor rapamycin46, sarco/endoplasmic reticulum (ER) Ca2+-ATPase (SERCA) inhibitor stemphol18 or the naphthoquinone shikonin47. The gene discussed is MTOR; the disease is cancer.